Overview of Global Brachytherapy Treatment Planning Systems Market to 2030

0

DUBLIN, March 29, 2022 /PRNewswire/ —

The “Brachytherapy Treatment Planning Systems Market Size, Share and Trend Analysis Report by Component (Deformable PET/CT, Auto Contour Software), by Technique (3D Image Reconstruction, Imaging room) and segment forecast, 2022-2030″ has been added to from ResearchAndMarkets.com offer.

The Global brachytherapy The Treatment Planning Systems Market Size is Expected to Reach USD 1.5 billion by 2030, registering a CAGR 9.3% over the forecast period.

The global prevalence of cancer and cancer-related mortality is increasing rapidly and driving demand for innovative cancer care solutions. According to Globocan 2020 estimates, in 2020, 19.3 million new cases of cancer were detected worldwide. Some of the most commonly diagnosed cases of cancer are breast cancer, prostate cancer, lung cancer, and colorectal cancer. According to the WHO, cancer is one of the leading causes of death globally, claiming one in six deaths.

The dramatic increase in cancer prevalence is driving the demand for innovative cancer treatments with precise and accurate results. The oncology care industry is witnessing an increase in innovations and investments by key players developing new technologies, which are expected to significantly transform the cancer care treatment regime. Ever-changing healthcare infrastructure, rising healthcare IT spending and shrinking growth opportunities in emerging economies are propelling the growth of the market. Various bodies and government agencies around the world encourage public-private partnerships to boost product development strategies.

Along with the increasing prevalence of cancer, the growing number of radiotherapy centers with technologies for better brachytherapy treatment planning is driving the growth of the market. In recent years, the number of well-developed and technologically advanced radiotherapy centers is increasing. The adoption of brachytherapy treatment planning and patient care management is increasing due to the availability of better radiotherapy centers, public-private partnerships for setting up better facilities, and strategic stakeholder collaborations majors with radiotherapy centers to provide technologically advanced machines with improved treatment planning. and delivery software and tools.

Highlights of the Brachytherapy Treatment Planning Systems Market Report

  • In 2021, automatic contouring software segment dominated the market due to multiple advantages offered by automatic contouring software over manual contouring
  • In-chamber imaging segment led the market in 2021 due to reduced therapeutic uncertainties and improved precision treatment
  • North America was the largest regional market in 2021 due to high prevalence of cancer and presence of favorable reimbursement framework and advanced healthcare infrastructure
  • Market players are integrating artificial intelligence (AI) and machine learning (ML) algorithms into their product offerings to improve screening and diagnosis, simulation, treatment planning and care management
  • The integration of AI/ML has dramatically improved the clinical decision support, data mining, diagnosis, and imaging segments of oncology care. These algorithms can be used for image segmentation and detection of clinically important areas
  • According to Renal & Urology News, in February 2020AI algorithms embedded in cancer care have had a positive impact on the effectiveness of brachytherapy in men with prostate cancer
  • Massive stacking and accumulation of cancer-related data, growing need for rapid diagnosis, and high demand for tailored cancer treatment plans are driving the adoption of AI/ML in oncology

Main topics covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Brachytherapy Treatment Planning Systems Market Variables, Trends and Scope
3.1 Market Segmentation and Scope
3.2 Mapping of penetration and growth prospects
3.3 Market Penetration Trends
3.4 Market Driver Analysis
3.4.1 Increase in cancer prevalence
3.4.2 Increase investments and strategic initiatives in radiotherapy
3.4.3 Growing number of radiotherapy centers and hospitals adopting technologically advanced radiotherapy machines and software
3.4.4 Growing Adoption of Ai/Ml in Oncology Software
3.4.5 Real-time monitoring and tracking of cancer progression
3.5 Market Restraint Analysis
3.5.1 Shortage of healthcare personnel in the information technology and radiology sector
3.5.2 Capital intensive market
3.5.3 Cybersecurity and privacy issues
3.6 Brachytherapy Treatment Planning Systems Industry Analysis – Porter’s Five Analysis
3.6.1 Bargaining power of suppliers: low
3.6.2 Bargaining power of buyers: low
3.6.3 Threat of Substitution: Low
3.6.4 Threats from new entrants: low
3.6.5 Competitive Rivalry: High
3.7 Brachytherapy Treatment Planning Systems – PEST Industry Analysis
3.7.1 Political and legal landscape
3.7.2 Economic and social landscape
3.7.3 Technology landscape
3.8 Reimbursement scenario
3.8.1 United States
3.9 Price Analysis
3.10 Types of Business Models for Brachytherapy Treatment Planning Systems – Case Study
3.11 Major transactions and strategic alliances
3.12 Impact of COVID-19 on the Brachytherapy Treatment Planning Systems Market

Chapter 4 Brachytherapy Treatment Planning Systems Market: Component Estimates and Trend Analysis
4.1 Brachytherapy Treatment Planning Systems Market: Component Movement Analysis, USD Million, 2021 & 2030
4.1.1 Automatic contouring software
4.1.1.1 Automatic Bypass Software Revenue Estimates and Forecasts, 2017- 2030 (USD Million)
4.1.2 Multimodality software
4.1.2.1 Multimodality Software Revenue Estimates and Forecasts, 2017- 2030 (USD Million)
4.1.3 Deformable PET/CT software
4.1.3.1 Deformable Pet/Ct Software Revenue Estimates and Forecasts, 2017- 2030 (USD Million)
4.1.4 DICOM-RT Software
4.1.4.1 Dicom-Rt Software Revenue Estimates and Forecasts, 2017- 2030 (USD Million)
4.2 List of Components Segment Key Players

Chapter 5 Brachytherapy Treatment Planning Systems Market: Technical Estimates and Trend Analysis
5.1 Brachytherapy Treatment Planning Systems Market: Technical Movement Analysis, USD Million, 2021 & 2030
5.2 Reconstruction of 3D images
5.2.1 3D Image Reconstruction Revenue Estimates and Forecasts, 2017-2030 (USD Million)
5.3 In-chamber imaging
5.3.1 Imaging Revenue Estimates and Forecasts, 2017-2030 (USD Million)
5.4 Image recording using a graphics processing unit (GPU)
5.4.1 Image Recording Using GPUs Revenue Estimates and Forecasts, 2017- 2030 (Million USD)
5.5 List of Technical Segment Key Players

Chapter 6 Brachytherapy Treatment Planning Systems Market: Competitive Analysis
6.1 Recent Developments and Impact Analysis, by Major Market Players
6.2 Categorization of Companies/Competitors (Key Innovators, Market Leaders, Emerging Players)
6.3 Company Market Position Analysis

Chapter 7 Brachytherapy Treatment Planning Systems Market: Regional Estimates and Trend Analysis by Component and Technique

Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Elekta AB
8.1.1.1 Presentation of the company
8.1.1.2 Financial performance
8.1.1.3 Product Benchmarking
8.1.1.4 Strategic initiatives
8.1.2 MIM, Inc. Software
8.1.2.1 Presentation of the company
8.1.2.2 Financial performance
8.1.2.3 Product Benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Prowess, Inc.
8.1.3.1 Presentation of the company
8.1.3.2 Financial performance
8.1.3.3 Product Benchmarking
8.1.4 Varian Medical Systems, Inc.
8.1.4.1 Presentation of the company
8.1.4.2 Financial performance
8.1.4.3 Product Benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Raysearch Laboratories
8.1.5.1 Presentation of the company
8.1.5.2 Financial performance
8.1.5.3 Product Benchmarking
8.1.5.4 Strategic initiatives
8.2 List of other companies

For more information about this report visit https://www.researchandmarkets.com/r/jhzwnz

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets

Share.

Comments are closed.